Working… Menu

Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02953860
Recruitment Status : Recruiting
First Posted : November 3, 2016
Last Update Posted : December 13, 2018
United States Department of Defense
Information provided by (Responsible Party):
University of Colorado, Denver

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2020
Estimated Study Completion Date : November 2021